China Nuokang Bio-Pharmaceutical Inc. - American depositary shares, each representing eight ordinary shares (NKBP)

5.54
NASDAQ
Prev Close 5.54
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Shares Outstanding 157.33M
Div & Yield N.A. (N.A)

Latest News

Rosen Law Firm Announces Investigation Of China Nuokang Bio-Pharmaceutical In Connection With Going Private Proposal From Kingbird Investment Inc. – NKBP

Rosen Law Firm Announces Investigation Of China Nuokang Bio-Pharmaceutical In Connection With Going Private Proposal From Kingbird Investment Inc. – NKBP

The Rosen Law Firm is investigating the Board of Directors of China Nuokang Bio-Pharmaceutical Inc.

CHINA NUOKANG BIO-PHARMACEUTICAL Inc. Stock Upgraded (NKBP)

CHINA NUOKANG BIO-PHARMACEUTICAL Inc. Stock Upgraded (NKBP)

CHINA NUOKANG BIO-PHARMACEUTICAL (Nasdaq:NKBP) has been upgraded by TheStreet Ratings from a sell to hold.

CHINA NUOKANG BIO-PHARMACEUTICAL Inc. Stock Downgraded (NKBP)

CHINA NUOKANG BIO-PHARMACEUTICAL Inc. Stock Downgraded (NKBP)

CHINA NUOKANG BIO-PHARMACEUTICAL (Nasdaq:NKBP) has been downgraded by TheStreet Ratings from from a hold to sell.

CHINA NUOKANG BIO-PHARMACEUTICAL Inc. Stock Upgraded (NKBP)

CHINA NUOKANG BIO-PHARMACEUTICAL Inc. Stock Upgraded (NKBP)

CHINA NUOKANG BIO-PHARMACEUTICAL (Nasdaq:NKBP) has been upgraded by TheStreet Ratings from a sell to hold.

CHINA NUOKANG BIO-PHARMACEUTICAL Inc. Stock Downgraded (NKBP)

CHINA NUOKANG BIO-PHARMACEUTICAL (Nasdaq:NKBP) has been downgraded by TheStreet Ratings from from a hold to sell.

CHINA NUOKANG BIO-PHARMACEUTICAL Inc. Stock Upgraded (NKBP)

CHINA NUOKANG BIO-PHARMACEUTICAL (Nasdaq:NKBP) has been upgraded by TheStreet Ratings from a sell to hold.

China Nuokang Bio-Pharmaceutical Provides Update On Dipyridamole Aspirin

Receives Manufacturing License for Dipyridamole Aspirin

China Nuokang Bio-Pharmaceutical Provides Update On Kaitong

SFDA Issues Manufacturing License for Kaitong